Product review: the Disability Discrimination Act, currently being phased in, contains a wide range of measures which will have an enormous effect on the way buildings are designed and managed

Article Abstract:

The Disability Discrimination Act (DDA) 1995 aims to deal with discrimination against disabled people and will have a significant impact on building design and management. Some specialist organisations are offering access audits that can identify problems and explain what type of improvement might be desirable. Lifts, stairs and general access systems are described.

Buildings, Access for the disabled

---

New East Enders

Article Abstract:

In London's Docklands there are two new residential developments that illustrate the stunning effects that patterned brickwork can achieve. Architect Robert MacDonald Associates has designed buildings in alternating courses of of bright red and yellow bricks.

Services, Housing development, Robert MacDonald Associates

---

Home grown virtues

Article Abstract:

The restoration and conversion of the Arts and Crafts mansion Ashwood House, Woking, are described. The difficulties of restoring the building and adding new blocks of houses in the same style in a very successful, sympathetic way are explored.

Housing, Influence, Dwellings, Architecture, Remodeling and renovation, Historic buildings, Arts and crafts movement, Structural elements (Construction)

Similar abstracts:

• Abstracts: Cancelling the resevation?: Does the Secretary of State have the power to call-in reserved matters? Why reserved matters matter
• Abstracts: Properties of expected costs and performance measures in stochastic models of scheduled transport. A moment based metric for 2-D and 3-D packing
• Abstracts: Yacht velocity prediction using mathematical programming. Minimizing number of tardy jobs on a batch processing machine with incompatible job families
• Abstracts: Practical problems in applying the section 367 regulations to outbound transfers of a publicly traded domestic corporation's stock
• Abstracts: SmithKline shares fall on Avandia blow; EU panel fails to approve antidiabetes drug. Genmab admirers should examine some relationships

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.